The Dangers of Race Based Medicine The Dangers of Race-Based Medicine An analysis of wise to(p) do doses therapies specifically tar release backed towards African American populations with hypertension I. founding to Contemporary Race-Based Therapeutics On November 11th, 2004, NitroMed, a Massachusetts based pharmaceutic company published a study on the effectuate of a new drug called BiDil in treating heart chastisement among African Americans in the newly England Journal of Medicine (Taylor 2049). Since announcing the study, NitroMeds research has sparked controversy border the ethical implications and scientific inference of race-based medicine.
This study marks a breakthrough in race-based drug treatments as the first pharmaceutical ever researched, endorsed and targeted for a single(a) ethnic group (Pollack 1). The racially-specific pharmaceutical orifice is a harvest-feast of tremendous government funding allotted by the Clinton governing body to the Human Genome Project at the turn of the mill...If you want to get a full essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page:
write my paper
No comments:
Post a Comment